XNASACCD
Market cap558mUSD
Jan 14, Last price
6.84USD
1D
0.15%
1Q
82.40%
IPO
-77.20%
Name
Accolade Inc
Chart & Performance
P/E
—
P/S
1.35
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
16.68%
Rev. gr., 5y
34.30%
Revenues
414m
+14.09%
Net income
-100m
L-78.29%
CFO
-16m
L-60.28%
Earnings
Apr 23, 2025
Profile
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | |
| Income | |||||||
Revenues | 414,292 14.09% | 363,142 17.13% | 310,021 81.98% | ||||
Cost of revenue | 483,581 | 480,574 | 438,554 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (69,289) | (117,432) | (128,533) | ||||
NOPBT Margin | |||||||
Operating Taxes | 1,235 | (3,624) | (5,639) | ||||
Tax Rate | |||||||
NOPAT | (70,524) | (113,808) | (122,894) | ||||
Net income | (99,805) -78.29% | (459,650) 273.32% | (123,124) 143.08% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 4,991 | 455,586 | |||||
BB yield | -0.63% | -39.70% | |||||
| Debt | |||||||
Debt current | 7,089 | 7,880 | 6,589 | ||||
Long-term debt | 267,287 | 343,985 | 352,227 | ||||
Deferred revenue | 121 | 154 | 268 | ||||
Other long-term liabilities | 156 | 203 | 4,562 | ||||
Net debt | 37,343 | 30,782 | (7,037) | ||||
| Cash flow | |||||||
Cash from operating activities | (16,169) | (40,705) | (62,350) | ||||
CAPEX | (4,935) | (7,228) | (3,617) | ||||
Cash from investing activities | (63,629) | (7,228) | (263,613) | ||||
Cash from financing activities | (55,567) | 3,163 | 257,932 | ||||
FCF | (73,716) | (113,173) | (158,590) | ||||
| Balance | |||||||
Cash | 237,033 | 321,083 | 365,853 | ||||
Long term investments | |||||||
Excess cash | 216,318 | 302,926 | 350,352 | ||||
Stockholders' equity | (1,054,138) | (954,287) | (494,637) | ||||
Invested Capital | 1,741,528 | 1,730,128 | 1,674,233 | ||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | 74,907 | 71,280 | 63,823 | ||||
Price | 10.25 -7.74% | 11.11 -38.21% | 17.98 -59.43% | ||||
Market cap | 767,796 -3.05% | 791,919 -30.99% | 1,147,542 -11.84% | ||||
EV | 805,139 | 822,701 | 1,140,505 | ||||
EBITDA | (24,125) | (71,055) | (85,925) | ||||
EV/EBITDA | |||||||
Interest | 255 | 2,905 | |||||
Interest/NOPBT | |||||||